Iaso Therapeutics

East Lansing, United States

Iaso Therapeutics develops vaccines to improve human health and cure diseases.

$125K raised

Jan 2023

Grant

Biotechnology Health Care Medical Therapeutics

Top Investors

National Science Foundation Michigan Rise Red Cedar Ventures National Institute of Allergy and Infectious Diseases Michigan Emerging Technology Fund

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Iaso Therapeutics

How much funding has Iaso Therapeutics raised?

Iaso Therapeutics has raised $125K in total funding. The most recent round was Grant. The last funding was announced in January 2023.

Who are Iaso Therapeutics's investors?

Iaso Therapeutics's investors include National Science Foundation, Michigan Rise, Red Cedar Ventures, National Institute of Allergy and Infectious Diseases, Michigan Emerging Technology Fund.

Where is Iaso Therapeutics headquartered?

Iaso Therapeutics is headquartered in East Lansing, United States.

What does Iaso Therapeutics do?

Iaso Therapeutics develops vaccines to improve human health and cure diseases.

What stage is Iaso Therapeutics at?

Iaso Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 25, 2023.

MLA

"Iaso Therapeutics — Funding & Investors." VCBacked, January 25, 2023, https://www.vcbacked.co/company/iaso-therapeutics. Accessed July 4, 2026.

APA

VCBacked. (2023). Iaso Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/iaso-therapeutics

Wikipedia (cite web)

{{cite web |title=Iaso Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/iaso-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 25, 2023.